Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Pieper Steven sold 45,000 Xeris Biopharma Holdings, Inc. shares (Form 4)
Traded Jul 6 to Jul 7, 2026 · Filed Jul 7, 2026
From Jul 6 to Jul 7, 2026, Pieper Steven (See Remarks) sold 45,000 Xeris Biopharma Holdings, Inc. shares at an average US$8.51 for US$383K under a trading plan, leaving 1,366,053 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 45,000 shares
- Price
- US$8.51 average (US$8.50 to US$8.52)
- Value
- US$383K
- Holding after
- 1,366,053 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Sale | 17,400 | US$8.50 | 1,393,653 | Direct |
| Jul 7, 2026 | Common Stock | Sale | 27,600 | US$8.52 | 1,366,053 | Direct |
Source
Related
- Xeris Biopharma Holdings, Inc.
- Pieper Steven
- Xeris Biopharma Holdings, Inc. shareholders
- Form 4 · Pieper Steven · Oct 2, 2026
- Form 4 · Pieper Steven · Sep 1, 2026
- Form 4 · Pieper Steven · Aug 12, 2026
- Form 4 · Hecht Beth · Oct 2, 2026
- Form 4 · McCulloch Kevin · Oct 2, 2026
- Form 4 · McCulloch Kevin · Sep 29, 2026
- Form 4 · McCulloch Kevin · Sep 1, 2026
- Form 4 · Hecht Beth · Sep 1, 2026